Associated Papers
Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy.
Bagyinszky E et al.
Cells, 2023
DNA Methylation Analysis in Monozygotic Twins Discordant for ALS in Blood Cells.
Yazar V et al.
Epigenetics Insights, 2023
Characterising the Genetic Landscape of Amyotrophic Lateral Sclerosis: A Catalogue and Assessment of Over 1,000 Published Genetic Variants.
McCann EP et al.
Journal of Neuromuscular Diseases, 2023
37638449 (PubMed )
Supplement: jnd-10-jnd230148-s001.xlsx › variant_list
Genetic factors for survival in amyotrophic lateral sclerosis: an integrated approach combining a systematic review, pairwise and network meta-analysis.
Su WM et al.
Bmc Medicine, 2022
NEK1 Variants in a Cohort of Italian Patients With Amyotrophic Lateral Sclerosis.
Riva N et al.
Frontiers in Neuroscience, 2022
35495032 (PubMed )
Supplement: Data_Sheet_1.docx
Hand-onset weakness is a common feature of ALS patients with a NEK1 loss-of-function variant.
Tsai YS et al.
Annals of Clinical and Translational Neurology, 2020
NEK1 mutations in familial amyotrophic lateral sclerosis.
Brenner D et al.
Brain : a Journal of Neurology, 2016
Select a paper to view details